Rothschild & CO Asset Management Us Inc. Abbott Laboratories Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 93,143 shares of ABT stock, worth $9.53 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

93,143

Previous 94,822 1.77%

Holding current value

$9.53 Million

Previous $9.18 Million 11.48%

% of portfolio

0.16%

Previous 0.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $159,605 - $187,242	-1,679 Reduced 1.77%	93,143 $10.2 Million
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $549,306 - $635,994	5,677 Added 6.37%	94,822 $9.18 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $842,179 - $1.02 Million	8,251 Added 10.2%	89,145 $9.69 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $33,407 - $40,738	-293 Reduced 0.36%	80,894 $9.57 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $428,731 - $524,958	-3,711 Reduced 4.37%	81,187 $11.4 Million

Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $149,441 - $165,325	-1,281 Reduced 1.49%	84,898 $10 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $216,763 - $255,161	-2,049 Reduced 2.32%	86,179 $9.99 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $415,442 - $489,453	-3,817 Reduced 4.15%	88,228 $10.6 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $689,745 - $751,624	6,569 Added 7.69%	92,045 $10.1 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $11.4 Million - $13.8 Million	-124,259 Reduced 59.25%	85,476 $9.3 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $3.85 Million - $4.93 Million	-50,268 Reduced 19.33%	209,735 $19.2 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $815,466 - $1.19 Million	-12,981 Reduced 4.76%	260,003 $20.5 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $403,855 - $449,585	-5,144 Reduced 1.85%	272,984 $23.7 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $969,149 - $1.05 Million	-11,842 Reduced 4.08%	278,128 $23.3 Million
Q2 2019 Jul 25, 2019	BUY	$72.88 - $85.0 $19.9 Million - $23.3 Million	273,579 Added 1669.08%	289,970 $24.4 Million
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $76,682 - $92,709	1,158 Added 7.6%	16,391 $1.31 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $86,735 - $98,259	-1,323 Reduced 7.99%	15,233 $1.1 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $54,972 - $66,317	904 Added 5.78%	16,556 $1.22 Million
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $901,085 - $994,528	15,652 New	15,652 $955,000
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $405,606 - $434,243	-7,556 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $363,141 - $405,303	7,556	7,556 $403,000

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Abbott Laboratories Transaction History